Synthesis and biological evaluation of a new series of phenothiazine-containing protein farnesyltransferase inhibitors

被引:25
作者
Abuhaie, Cristina-Maria [1 ]
Ghinet, Alina [1 ,2 ,3 ]
Farce, Amaury [2 ,4 ]
Dubois, Joelle [5 ]
Gautret, Philippe [2 ,3 ]
Rigo, Benoit [2 ,3 ]
Belei, Dalila [1 ]
Bicu, Elena [1 ]
机构
[1] Alexandru Ioan Cuza Univ, Dept Organ Chem, Fac Chem, Iasi 700506, Romania
[2] Univ Lille Nord France, F-59000 Lille, France
[3] UCLille, HEI, Lab Pharmacochim, EA GRIIOT 4481, F-59046 Lille, France
[4] Inst Chim Pharmaceut Albert Lespagnol, EA GRIIOT 4481, IFR114, F-59006 Lille, France
[5] CNRS, Ctr Rech Gif, Inst Chim Subst Nat, UPR 2301, F-91198 Gif Sur Yvette, France
关键词
Phenothiazine; Fanesyltransferase inhibitors; Ylide; Pyridin-(1H)-ylidene; Anticancer agent; FARNESYL TRANSFERASE INHIBITORS; N-ACYLPHENOTHIAZINE; DERIVATIVES; DISCOVERY; CANCER; CHEMOTHERAPY; VALIDATION; CHEMISTRY; YLIDES; POTENT;
D O I
10.1016/j.ejmech.2012.11.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two new families of human farnesyltransferase inhibitors 13a-m and 14a-d, based on a phenothiazine scaffold, were synthesized. Compounds 14a and 14b were the most promising inhibitors of human farnesyltransferase with IC50 values of 0.7 and 0.6 mu M, respectively. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:101 / 110
页数:10
相关论文
共 35 条
  • [1] Benzoindolizine derivatives of N-acylphenothiazine.: Synthesis and characterization
    Bâcu, E
    Samson-Belei, D
    Nowogrocki, G
    Couture, A
    Grandclaudon, P
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2003, 1 (13) : 2377 - 2382
  • [2] Bâcu E, 2006, REV ROUM CHIM, V51, P887
  • [3] Bacu E, 2007, REV ROUM CHIM, V52, P253
  • [4] Banerjee S., 2005, Curr. Enzyme Inhib, V1, P183
  • [5] Preclinical and clinical evaluation of farnesyltransferase inhibitors
    Charles Baum
    Paul Kirschmeier
    [J]. Current Oncology Reports, 2003, 5 (2) : 99 - 107
  • [6] New farnesyltransferase inhibitors in the phenothiazine series
    Belei, Dalila
    Dumea, Carmen
    Samson, Alexandrina
    Farce, Amaury
    Dubois, Joelle
    Bicu, Elena
    Ghinet, Alina
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4517 - 4522
  • [7] Inhibitors of farnesyltransferase: A rational approach to cancer chemotherapy?
    Bell, IM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (08) : 1869 - 1878
  • [8] 3-aminopyrrolidinone farnesyltransferase inhibitors: Design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency
    Bell, IM
    Gallicchio, SN
    Abrams, M
    Beese, LS
    Beshore, DC
    Bhimnathwala, H
    Bogusky, MJ
    Buser, CA
    Culberson, JC
    Davide, J
    Ellis-Hutchings, M
    Fernandes, C
    Gibbs, JB
    Graham, SL
    Hamilton, KA
    Hartman, GD
    Heimbrook, DC
    Homnick, CF
    Huber, HE
    Huff, JR
    Kassahun, K
    Koblan, KS
    Kohl, NE
    Lobell, RB
    Lynch, JJ
    Robinson, R
    Rodrigues, AD
    Taylor, JS
    Walsh, ES
    Williams, TM
    Zartman, CB
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) : 2388 - 2409
  • [9] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [10] 5-HYDROXYTRYPTAMINE (5-HT3) RECEPTOR ANTAGONISTS .1. INDAZOLE AND INDOLIZINE-3-CARBOXYLIC ACID-DERIVATIVES
    BERMUDEZ, J
    FAKE, CS
    JOINER, GF
    JOINER, KA
    KING, FD
    MINER, WD
    SANGER, GJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) : 1924 - 1929